The best regenerative biomaterial:
HUMAN COLLAGEN
Ethical and Sustainable Collagen by Scientific Excellence
Arrakis Bio offers human-derived Collagen, ensuring tissue specificity, safety, quality assurance, and sustainable production, setting a new standard for biocompatibility and efficacy.
Our Vision: Arrakis Bio is committed to revolutionizing Collagen production through innovative, sustainable, and ethical practices. Our team of experts is dedicated to advancing the science of human Collagen for a healthier, more beautiful future.
Discover the diverse applications of human Collagen in regenerative medicine.
Rising Trend, High Demand
THE MOMENT IS NOW
COLLAGEN
IN NUMBERS
Facts & Figures
Advanced Collagen wound dressing
50%
accelerated healing of wounds.
Fastest growing segment in Aesthetics
20%
Market Share Size in 2024
1%
every year after the age of 30.
Our body loses Collagen
30%
of you is Collagen.
Most abundant protein in our body
Optimized Fibroblast Cell Lines
Designed for industrial-scale collagen production, our immortalized human fibroblasts are engineered for scalable and long-term culture stability, eliminating the need for repeated primary cell sourcing. Their robust expression of Type I collagen enables consistent, high-yield bio-manufacturing, streamlining upstream processing and reducing production costs.
Our Technology
A CELL-PAVED HIGHWAY TO THE FUTURE OF COLLAGEN
Arrakis Bio's proprietary technology is redefining Collagen production. Our platform features optimized human fibroblast cell lines, advanced metabolic engineering, high-purity extraction, and a scalable bio-manufacturing process, ensuring unparalleled quality and consistency.
Metabolic Engineering
Custom-formulated cell culture media that is specifically optimized to enhance collagen yields by activating key metabolic pathways involved in collagen biosynthesis. By precisely controlling nutrient composition and signaling factors, the media promotes sustained fibroblast productivity and maximizes Type I collagen output under scalable, serum-free conditions.
High-Purity Extraction
Downstream process that is designed for cost-effective, high-yield recovery of clinical-grade Type I collagen, integrating scalable extraction, selective separation, and multi-step purification under GMP-compliant conditions. This streamlined workflow preserves collagen's native triple-helix structure while ensuring exceptional purity, consistency, and regulatory readiness for therapeutic and medical applications.
Scalable
Bio-Manufacturing Platform
A proprietary and economically viable biomanufacturing platform that is engineered to produce true human collagen at a visionary scale and cost. Built for industrial throughput and uncompromising quality, the platform enables reliable, cost effective animal-free production of true human collagen for regenerative, aesthetics and biomedical applications.
X50 Improved Production Rate
Through targeted cell line selection and media innovation, we've achieved a 50-fold increase in collagen production compared to baseline human fibroblast cultures. This breakthrough dramatically reduces production costs and demonstrates a pivotal step toward making human collagen bio-manufacturing commercially viable at scale.
Our Technology
A CELL-PAVED HIGHWAY TO THE FUTURE OF COLLAGEN
Arrakis Bio's proprietary technology is redefining Collagen production. Our platform features optimized human fibroblast cell lines, advanced metabolic engineering, high-purity extraction, and a scalable bio-manufacturing process, ensuring unparalleled quality and consistency.
Optimized Fibroblast Cell Lines
Designed for industrial-scale collagen production, our immortalized human fibroblasts are engineered for scalable and long-term culture stability, eliminating the need for animal-derived inputs or repeated primary cell sourcing. Their robust expression of Type I collagen enables consistent, high-yield bio-manufacturing, streamlining upstream processing and reducing production costs.
Metabolic Engineering
Custom-formulated cell culture media that is specifically optimized to enhance collagen yields by activating key metabolic pathways involved in collagen biosynthesis. By precisely controlling nutrient composition and signaling factors, the media promotes sustained fibroblast productivity and maximizes Type I collagen output under scalable, serum-free conditions.
High-Purity Extraction
Downstream process that is designed for cost-effective, high-yield recovery of clinical-grade Type I collagen, integrating scalable extraction, selective separation, and multi-step purification under GMP-compliant conditions. This streamlined workflow preserves collagen's native triple-helix structure while ensuring exceptional purity, consistency, and regulatory readiness for therapeutic and medical applications.
Scalable
Bio-Manufacturing Platform
A proprietary and economically viable biomanufacturing platform that is engineered to produce true human collagen at a visionary scale and cost. Built for industrial throughput and uncompromising quality, the platform enables reliable, cost effective animal-free production of true human collagen for regenerative, aesthetics and biomedical applications.
X50 Improved Production Rate
Through targeted cell line selection and media innovation, we've achieved a 50-fold increase in collagen production compared to baseline human fibroblast cultures. This breakthrough dramatically reduces production costs and demonstrates a pivotal step toward making human collagen bio-manufacturing commercially viable at scale.
ARRAKIS BIO TRUE COLLAGEN:
Human
Humane
Safe
Scalable
Sustainable
Pure
Natural
Affordable
Compatible
Regenerative
